2015 Guidance on cancer immunotherapy development in early‐phase clinical studies

The development of cancer immunotherapies is progressing rapidly with a variety of technological approaches. They consist of “cancer vaccines”, which are based on the idea of vaccination, “effector cell therapy”, classified as passive immunotherapy, and “inhibition of immunosuppression”, which inten...

Descripción completa

Detalles Bibliográficos
Autores principales: Arato, Teruyo, Daimon, Takashi, Heike, Yuji, Ishii, Ken, Itho, Kyogo, Kageyama, Shinichi, Kawakami, Yutaka, Nakayama, Eiichi, Ozawa, Keiya, Sato, Noriyuki, Shiku, Hiroshi, Takeuchi, Masahiro, Tani, Kenzaburo, Tamada, Koji, Ueda, Ryuzo, Yamaguchi, Yoshiyuki, Yamanaka, Takeharu, Yamaue, Hiroki, Yasukawa, Masaki, Iguchi, Toyotaka, Kitano, Shigehisa, Miyahara, Yoshihiro, Nagata, Yasuhiro, Noguchi, Masanori, Terashima, Takeshi, Asano, Takeo, Asonuma, Motohiro, Ikeda, Hiroaki, Kakimi, Kazuhiro, Takesako, Kazutoh, Tanaka, Masanori, Amakasu, Kohei, Yamada, Akira, Harada, Naozumi, Aoshi, Taiki, Kuroda, Etsushi, Kobiyama, Kouji, Muraoka, Daisuke, Yamazaki, Naoya, Kuchiba, Aya, Tanaka, Shiro, Michimae, Hirofumi, Yamada, Tomomi, Hanada, Kenichi, Okada, Hideho, Takebe, Naoko, Hirano, Naoto, Okumura, Satoshi, Sato, Daisaku, Shibatsuji, Masayoshi, Yamaguchi, Teruhide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714668/
https://www.ncbi.nlm.nih.gov/pubmed/26767933
http://dx.doi.org/10.1111/cas.12819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714668/
https://www.ncbi.nlm.nih.gov/pubmed/26767933
http://dx.doi.org/10.1111/cas.12819

Ejemplares similares